BIOE
Get informed when a big investor buys or sells
+ FollowOvervalued by 132.2% based on the discounted cash flow analysis.
| Market cap | $10.57 Million |
|---|---|
| Enterprise Value | $12.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.02 |
| Beta | 6.1 |
| Outstanding Shares | 50,885,923 |
| P/E Ratio | 7.16 |
|---|---|
| PEG | 2.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.2 |
| Enterprise Value to EBIT | 7.94 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, ca...